{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T05:18:21Z","timestamp":1790831901339,"version":"4.1.0"},"update-to":[{"DOI":"10.1002\/14651858.cd011780","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2019,12,19]],"date-time":"2019-12-19T00:00:00Z","timestamp":1576713600000}}],"reference-count":72,"publisher":"Wiley","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd011780.pub2","type":"journal-article","created":{"date-parts":[[2019,12,20]],"date-time":"2019-12-20T05:05:07Z","timestamp":1576818307000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Equivalent schedules of intradermal fractional dose versus intramuscular full dose of inactivated polio vaccine for prevention of poliomyelitis"],"prefix":"10.1002","author":[{"given":"Nishant","family":"Jaiswal","sequence":"first","affiliation":[{"name":"Postgraduate Institute of Medical Education and Research; ICMR Advanced Centre for Evidence-Based Child Health; Sector 12 Chandigarh India 160012"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shreya","family":"Singh","sequence":"additional","affiliation":[{"name":"Postgraduate Institute of Medical Education and Research; Department of Medical Microbiology; Research Block A, Sector 12 Chandigarh Chandigarh India 160012"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amit","family":"Agarwal","sequence":"additional","affiliation":[{"name":"Postgraduate Institute of Medical Education and Research; ICMR Advanced Centre for Evidence-Based Child Health; Sector 12 Chandigarh India 160012"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anil","family":"Chauhan","sequence":"additional","affiliation":[{"name":"Postgraduate Institute of Medical Education and Research; ICMR Advanced Centre for Evidence-Based Child Health; Sector 12 Chandigarh India 160012"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kiran K","family":"Thumburu","sequence":"additional","affiliation":[{"name":"Postgraduate Institute of Medical Education and Research; ICMR Advanced Centre for Evidence-Based Child Health; Sector 12 Chandigarh India 160012"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harpreet","family":"Kaur","sequence":"additional","affiliation":[{"name":"Panjab University; University Business School; Sector 14 Chandigarh India 160014"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meenu","family":"Singh","sequence":"additional","affiliation":[{"name":"Postgraduate Institute of Medical Education and Research; Department of Pediatrics; Sector 12 Chandigarh India 160012"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2019,12,19]]},"reference":[{"key":"10.1002\/14651858.CD011780.pub2-BIB0002|cit1","unstructured":"Anand A Regarding your published trial on IPV in the Vaccine journal [personal communication] Email to: N Jaiswal"},{"issue":"48","key":"10.1002\/14651858.CD011780.pub2-BIB0001|cit2","doi-asserted-by":"publisher","first-page":"6816","DOI":"10.1016\/j.vaccine.2015.09.039","article-title":"Early priming with inactivated poliovirus vaccine (IPV) and intradermal fractional dose IPV administered by a microneedle device: a randomized controlled trial","volume":"33","author":"Anand","year":"2015","journal-title":"Vaccine"},{"issue":"2","key":"10.1002\/14651858.CD011780.pub2-BIB0003|cit3","doi-asserted-by":"publisher","first-page":"e110","DOI":"10.1016\/j.ijid.2011.10.002","article-title":"Randomized controlled study of fractional doses of inactivated poliovirus vaccine administered intradermally with a needle in the Philippines","volume":"16","author":"Cadorna-Carlos","year":"2012","journal-title":"International Journal of Infectious Diseases"},{"issue":"8","key":"10.1002\/14651858.CD011780.pub2-BIB0004|cit4","doi-asserted-by":"publisher","first-page":"e534","DOI":"10.1016\/S2214-109X(16)30075-4","article-title":"Safety and immunogenicity of inactivated poliovirus vaccine when given with measles-rubella combined vaccine and yellow fever vaccine and when given via different administration routes: a phase 4, randomised, non-inferiority trial in The Gambia","volume":"4","author":"Clarke","year":"2016","journal-title":"Lancet. Global Health"},{"key":"10.1002\/14651858.CD011780.pub2-BIB0005|cit5","unstructured":"NCT01847872 IPV clinical trial - The Gambia (IPV) clinicaltrials.gov\/ct2\/show\/NCT01847872"},{"key":"10.1002\/14651858.CD011780.pub2-BIB0006|cit6","doi-asserted-by":"crossref","unstructured":"Est\u00edvarez CF Details regarding your published paper about \"Immunogenicity of supplemental doses of poliovirus vaccine for children aged 6-9 months in Moradabad, India: a community-based, randomised controlled trial. Lancet 2012 [personal communication] Email to: KK Thumburu","DOI":"10.1016\/S1473-3099(11)70190-6"},{"issue":"2","key":"10.1002\/14651858.CD011780.pub2-BIB0007|cit7","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/S1473-3099(11)70190-6","article-title":"Immunogenicity of supplemental doses of poliovirus vaccine for children aged 6-9 months in Moradabad, India: a community-based, randomised controlled trial","volume":"12","author":"Est\u00edvariz","year":"2012","journal-title":"Lancet. Infectious Diseases"},{"key":"10.1002\/14651858.CD011780.pub2-BIB0008|cit8","unstructured":"ACTRN12616000124437p Comparison of boosting of mucosal immunity after full and fractional dose of inactivated poliovirus vaccine, clinical trial in children in Sri Lanka, 2016 www.anzctr.org.au\/Trial\/Registration\/TrialReview.aspx?id=369725"},{"issue":"12","key":"10.1002\/14651858.CD011780.pub2-BIB0009|cit9","doi-asserted-by":"publisher","first-page":"1876","DOI":"10.1093\/infdis\/jiy389","article-title":"Boosting of mucosal immunity after fractional-dose inactivated poliovirus vaccine","volume":"218","author":"Gamage","year":"2018","journal-title":"Journal of Infectious Diseases"},{"issue":"25","key":"10.1002\/14651858.CD011780.pub2-BIB0010|cit10","doi-asserted-by":"publisher","first-page":"2351","DOI":"10.1056\/NEJMoa0909383","article-title":"Fractional doses of inactivated poliovirus vaccine in Oman","volume":"362","author":"Mohammed","year":"2010","journal-title":"New England Journal of Medicine"},{"issue":"9","key":"10.1002\/14651858.CD011780.pub2-BIB0011|cit11","doi-asserted-by":"publisher","first-page":"1344","DOI":"10.1086\/651611","article-title":"Randomized controlled clinical trial of fractional doses of inactivated poliovirus vaccine administered intradermally by needle-free device in Cuba","volume":"201","author":"Resik","year":"2010","journal-title":"Journal of Infectious Diseases"},{"issue":"5","key":"10.1002\/14651858.CD011780.pub2-BIB0012|cit12","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1056\/NEJMoa1202541","article-title":"Priming after a fractional dose of inactivated poliovirus vaccine","volume":"368","author":"Resik","year":"2013","journal-title":"New England Journal of Medicine"},{"key":"10.1002\/14651858.CD011780.pub2-BIB0013|cit13","unstructured":"Sutter RW Regarding your published paper about \"Priming after a Fractional Dose of Inactivated Poliovirus Vaccine\" published in NEJM 2013 [personal communication] Email to: KK Thumburu"},{"issue":"2","key":"10.1002\/14651858.CD011780.pub2-BIB0014|cit14","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1016\/j.vaccine.2014.11.025","article-title":"Immune responses after fractional doses of inactivated poliovirus vaccine using newly developed intradermal jet injectors: a randomized controlled trial in Cuba","volume":"33","author":"Resik","year":"2015","journal-title":"Vaccine"},{"issue":"2","key":"10.1002\/14651858.CD011780.pub2-BIB0015|cit15","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1093\/infdis\/jiw492","article-title":"Boosting immune responses following fractional-dose inactivated poliovirus vaccine: a randomized, controlled trial","volume":"215","author":"Resik","year":"2017","journal-title":"Journal of Infectious Diseases"},{"issue":"36","key":"10.1002\/14651858.CD011780.pub2-BIB0016|cit16","doi-asserted-by":"publisher","first-page":"3688","DOI":"10.1016\/j.vaccine.2013.05.104","article-title":"Intradermal fractional booster dose of inactivated poliomyelitis vaccine with a jet injector in healthy adults","volume":"31","author":"Soonawala","year":"2013","journal-title":"Vaccine"},{"issue":"1","key":"10.1002\/14651858.CD011780.pub2-BIB0017|cit17","first-page":"38","article-title":"Reactogenicity associated to the intradermally administered inactivated poliovirus vaccine with a needle-free injector","volume":"63","author":"Tejeda Fuentes","year":"2011","journal-title":"Revista Cubana de Medicina Tropical"},{"key":"10.1002\/14651858.CD011780.pub2-BIB0018|cit18","unstructured":"Troy S Regarding your paper \"Comparison of the Immunogenicity of Various Booster Doses of Inactivated Polio Vaccine Delivered Intradermally Versus Intramuscularly to HIV-Infected Adults\" [personal communication] Email to: A Agarwal"},{"issue":"12","key":"10.1002\/14651858.CD011780.pub2-BIB0019|cit19","doi-asserted-by":"publisher","first-page":"1969","DOI":"10.1093\/infdis\/jiu841","article-title":"Comparison of the immunogenicity of various booster doses of inactivated polio vaccine delivered intradermally versus intramuscularly to HIV-infected adults","volume":"211","author":"Troy","year":"2015","journal-title":"Journal of Infectious Diseases"},{"issue":"3","key":"10.1002\/14651858.CD011780.pub2-BIB0020|cit20","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1097\/01.inf.0000256735.05098.01","article-title":"Increased female-male mortality ratio associated with inactivated polio and diphtheria-tetanus-pertussis vaccines: observations from vaccination trials in Guinea-Bissau","volume":"26","author":"Aaby","year":"2007","journal-title":"Pediatric Infectious Disease Journal"},{"issue":"41","key":"10.1002\/14651858.CD011780.pub2-BIB0021|cit21","doi-asserted-by":"publisher","first-page":"7188","DOI":"10.1016\/j.vaccine.2011.05.079","article-title":"Inactivated polio vaccine development for technology transfer using attenuated Sabin poliovirus strains to shift from Salk-IPV to Sabin-IPV","volume":"29","author":"Bakker","year":"2011","journal-title":"Vaccine"},{"issue":"9","key":"10.1002\/14651858.CD011780.pub2-BIB0022|cit22","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1097\/00006454-199809000-00011","article-title":"Comparative reactogenicity and immunogenicity of booster doses of diphtheria-tetanus-acellular pertussis-inactivated poliovirus vaccine and diphtheria-tetanus-inactivated poliovirus vaccine in preadolescents","volume":"17","author":"B\u00e9gu\u00e9","year":"1998","journal-title":"Pediatric Infectious Disease Journal"},{"issue":"46","key":"10.1002\/14651858.CD011780.pub2-BIB0023|cit23","doi-asserted-by":"publisher","first-page":"8317","DOI":"10.1016\/j.vaccine.2011.08.099","article-title":"Attitudes and perceptions of private paediatricians regarding polio immunization in India","volume":"29","author":"Choudhury","year":"2011","journal-title":"Vaccine"},{"issue":"15","key":"10.1002\/14651858.CD011780.pub2-BIB0024|cit24","doi-asserted-by":"publisher","first-page":"1536","DOI":"10.1056\/NEJMoa054960","article-title":"Randomized, placebo-controlled trial of inactivated poliovirus vaccine in Cuba","volume":"356","author":"The Cuba IPV Study Collaborative Group","year":"2007","journal-title":"New England Journal of Medicine"},{"issue":"12","key":"10.1002\/14651858.CD011780.pub2-BIB0025|cit25","doi-asserted-by":"publisher","first-page":"1887","DOI":"10.1093\/infdis\/jiz026","article-title":"Poliovirus type 2 seroprevalence following full- or fractional-dose inactivated poliovirus vaccine in the period after Sabin type 2 withdrawal in Sri Lanka","volume":"219","author":"Gamage","year":"2019","journal-title":"Journal of Infectious Diseases"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD011780.pub2-BIB0026|cit26","doi-asserted-by":"publisher","first-page":"S439","DOI":"10.1093\/infdis\/jit601","article-title":"Immunogenicity and effectiveness of routine immunization with 1 or 2 doses of inactivated poliovirus vaccine: systematic review and meta-analysis","volume":"210","author":"Grassly","year":"2014","journal-title":"Journal of Infectious Diseases"},{"issue":"3","key":"10.1002\/14651858.CD011780.pub2-BIB0027|cit27","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1016\/j.vaccine.2011.10.065","article-title":"An open-label, randomized, multi-center study of the immunogenicity and safety of DTaP-IPV (KinrixTM) co-administered with MMR vaccine with or without varicella vaccine in healthy pre-school age children","volume":"30","author":"Klein","year":"2012","journal-title":"Vaccine"},{"issue":"12","key":"10.1002\/14651858.CD011780.pub2-BIB0028|cit28","doi-asserted-by":"publisher","first-page":"1436","DOI":"10.1016\/j.vaccine.2016.02.010","article-title":"Primary and booster vaccination with an inactivated poliovirus vaccine (IPV) is immunogenic and well-tolerated in infants and toddlers in China","volume":"34","author":"Li","year":"2016","journal-title":"Vaccine"},{"key":"10.1002\/14651858.CD011780.pub2-BIB0029|cit29","unstructured":"NCT00871000 Immunogenicity and safety of Boostrix polio vaccine as a booster dose in 5 to 6-year-old children clinicaltrials.gov\/ct2\/show\/NCT00871000"},{"issue":"9-10","key":"10.1002\/14651858.CD011780.pub2-BIB0030|cit30","doi-asserted-by":"publisher","first-page":"928","DOI":"10.1016\/s0264-410x(97)00293-4","article-title":"Immune response of infants to fractional doses of intradermally administered inactivated poliovirus vaccine","volume":"16","author":"Nirmal","year":"1998","journal-title":"Vaccine"},{"issue":"11","key":"10.1002\/14651858.CD011780.pub2-BIB0031|cit31","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.1016\/S1473-3099(15)00219-4","article-title":"Inactivated poliovirus vaccine given alone or in a sequential schedule with bivalent oral poliovirus vaccine in Chilean infants: a randomised, controlled, open-label, phase 4, non-inferiority study","volume":"15","author":"O'Ryan","year":"2015","journal-title":"Lancet. Infectious Diseases"},{"issue":"47","key":"10.1002\/14651858.CD011780.pub2-BIB0032|cit32","doi-asserted-by":"publisher","first-page":"5531","DOI":"10.1016\/j.vaccine.2013.09.021","article-title":"Safety and immunogenicity of inactivated poliovirus vaccine based on Sabin strains with and without aluminium hydroxide: a phase I trial in healthy adults","volume":"31","author":"Verdijk","year":"2013","journal-title":"Vaccine"},{"issue":"3","key":"10.1002\/14651858.CD011780.pub2-BIB0033|cit33","first-page":"253","article-title":"Combined immunization of infants with oral and inactivated poliovirus vaccines: results of a randomized trial in The Gambia, Oman, and Thailand","volume":"74","author":"WHO Collaborative Study Group on Oral and Inactivated Poliovirus Vaccines","year":"1996","journal-title":"Bulleten of the World Health Organization"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD011780.pub2-BIB0034|cit34","doi-asserted-by":"publisher","first-page":"S215","DOI":"10.1093\/infdis\/175.supplement_1.s215","article-title":"Combined immunization of infants with oral and inactivated poliovirus vaccines: results of a randomized trial in The Gambia, Oman, and Thailand","volume":"175","author":"WHO Collaborative Study Group on Oral and Inactivated Poliovirus Vaccines","year":"1997","journal-title":"Journal of Infectious Diseases"},{"key":"10.1002\/14651858.CD011780.pub2-BIB0035|cit35","unstructured":"NCT02347423 3 adjuvated reduced dose IPV-Al SSI and non-adjuvated full dose IPV SSI given as primary vaccinations to infants clinicaltrials.gov\/ct2\/show\/record\/NCT02347423"},{"key":"10.1002\/14651858.CD011780.pub2-BIB0036|cit36","unstructured":"NCT02847026 Fractional inactivated poliovirus vaccine booster and rotavirus study (fIPV) clinicaltrials.gov\/ct2\/show\/NCT02847026"},{"key":"10.1002\/14651858.CD011780.pub2-BIB0037|cit37","unstructured":"NCT03016949 A study to evaluate immunogenicity of various schedules of inactivated polio vaccine clinicaltrials.gov\/ct2\/show\/NCT03016949"},{"issue":"22","key":"10.1002\/14651858.CD011780.pub2-BIB0038|cit38","doi-asserted-by":"publisher","first-page":"2993","DOI":"10.1016\/j.vaccine.2017.03.008","article-title":"Immunogenicity to poliovirus type 2 following two doses of fractional intradermal inactivated poliovirus vaccine: a novel dose sparing immunization schedule","volume":"35","author":"Anand","year":"2017","journal-title":"Vaccine"},{"issue":"12","key":"10.1002\/14651858.CD011780.pub2-BIB0039|cit39","first-page":"253","article-title":"Progress toward global eradication of poliomyelitis, 2001","volume":"51","author":"Centers for Disease Control and Prevention","year":"2002","journal-title":"Morbidity and Mortality Weekly Report"},{"issue":"37","key":"10.1002\/14651858.CD011780.pub2-BIB0040|cit40","first-page":"768","article-title":"Assessing the risks for poliovirus outbreaks in polio-free countries - Africa, 2012-2013","volume":"62","author":"Centers for Disease Control and Prevention","year":"2013","journal-title":"Morbidity and Mortality Weekly Report"},{"issue":"8","key":"10.1002\/14651858.CD011780.pub2-BIB0041|cit41","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD011260","article-title":"Sequential inactivated (IPV) and live oral (OPV) poliovirus vaccines for preventing poliomyelitis","author":"Ciapponi","year":"2014","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"11","key":"10.1002\/14651858.CD011780.pub2-BIB0042|cit42","doi-asserted-by":"publisher","first-page":"1575","DOI":"10.1002\/sim.1188","article-title":"Issues in the selection of a summary statistic for meta-analysis of clinical trials with binary outcomes","volume":"21","author":"Deeks","year":"2002","journal-title":"Statistics in Medicine"},{"key":"10.1002\/14651858.CD011780.pub2-BIB0043|cit43","unstructured":"Deeks JJ Higgins JPT Altman DG editor(s) on behalf of the Cochrane Statistical Methods Group Chapter 9: Analysing data and undertaking meta-analysis. In: Higgins JPT, Green S, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from handbook.cochrane.org"},{"issue":"4","key":"10.1002\/14651858.CD011780.pub2-BIB0044|cit44","first-page":"311","article-title":"Can post-eradication laboratory containment of wild polioviruses be achieved?","volume":"80","author":"Dowdle","year":"2002","journal-title":"Bulletin of the World Health Organization"},{"key":"10.1002\/14651858.CD011780.pub2-BIB0045|cit45","unstructured":"Global Polio Eradication Initiative Polio + prevention bit.ly\/19VK8ok"},{"key":"10.1002\/14651858.CD011780.pub2-BIB0046|cit46","unstructured":"Global Polio Eradication Initiative Use of fractional dose IPV in routine immunization programmes: considerations for decision-making www.who.int\/immunization\/diseases\/poliomyelitis\/endgame_objective2\/inactivated_polio_vaccine\/fIPV_considerations_for_decision-making_April2017.pdf"},{"key":"10.1002\/14651858.CD011780.pub2-BIB0047|cit47","unstructured":"Global Polio Eradication Initiative Vaccine-derived polioviruses www.polioeradication.org\/polio-today\/polio-prevention\/the-virus\/vaccine-derived-polio-viruses\/"},{"key":"10.1002\/14651858.CD011780.pub2-BIB0048|cit48","unstructured":"McMaster University (developed by Evidence Prime) GRADEpro GDT"},{"issue":"1623","key":"10.1002\/14651858.CD011780.pub2-BIB0049|cit49","doi-asserted-by":"publisher","first-page":"20120140","DOI":"10.1098\/rstb.2012.0140","article-title":"The final stages of the global eradication of poliomyelitis","volume":"368","author":"Grassly","year":"2013","journal-title":"Philosophical Transitions of the Royal Society of London. Series B, Biological Sciences"},{"issue":"4","key":"10.1002\/14651858.CD011780.pub2-BIB0050|cit50","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1016\/j.jclinepi.2010.04.026","article-title":"GRADE guidelines: 1. Introduction - GRADE evidence profiles and summary of findings tables","volume":"64","author":"Guyatt","year":"2011","journal-title":"Journal of Clinical Epidemiology"},{"issue":"7414","key":"10.1002\/14651858.CD011780.pub2-BIB0051|cit51","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD011780.pub2-BIB0052|cit52","unstructured":"Higgins JPT Altman DG Sterne JAC editor(s) on behalf of the Cochrane Statistical Methods Group and the Cochrane Bias Methods Group Chapter 8: Assessing risk of bias in included studies. In: Higgins JPT, Green S, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from handbook.cochrane.org"},{"key":"10.1002\/14651858.CD011780.pub2-BIB0053|cit53","unstructured":"Higgins JPT Deeks JJ Altman DG editor(s) on behalf of the Cochrane Statistical Methods Group Chapter 16: Special topics in statistics. In: Higgins JPT, Green S, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from handbook.cochrane.org"},{"key":"10.1002\/14651858.CD011780.pub2-BIB0054|cit54","unstructured":"Higgins JPT Deeks JJ editor(s) Chapter 7: Selecting studies and collecting data. In: Higgins JP, Green S, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from handbook.cochrane.org"},{"issue":"26","key":"10.1002\/14651858.CD011780.pub2-BIB0055|cit55","doi-asserted-by":"publisher","first-page":"3197","DOI":"10.1016\/j.vaccine.2008.03.095","article-title":"Intradermal vaccine delivery: will new delivery systems transform vaccine administration?","volume":"26","author":"Lambert","year":"2008","journal-title":"Vaccine"},{"key":"10.1002\/14651858.CD011780.pub2-BIB0056|cit56","unstructured":"Lefebvre C Manheimer E Glanville J on behalf of the Cochrane Information Retrieval Methods Group Chapter 6: Searching for studies. In: Higgins JPT, Green S, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from handbook.cochrane.org"},{"key":"10.1002\/14651858.CD011780.pub2-BIB0057|cit57","doi-asserted-by":"publisher","first-page":"S447","DOI":"10.1093\/infdis\/jiu043","article-title":"Progress in the development of poliovirus antiviral agents and their essential role in reducing risks that threaten eradication","volume":"210 Suppl 1","author":"McKinlay","year":"2014","journal-title":"Journal of Infectious Diseases"},{"key":"10.1002\/14651858.CD011780.pub2-BIB0058|cit58","doi-asserted-by":"crossref","unstructured":"Minor P The polio endgame Human Vaccines & Immunotherapeutics 2014 2106 8 10.4161\/21645515.2014.981115","DOI":"10.4161\/21645515.2014.981115"},{"issue":"7","key":"10.1002\/14651858.CD011780.pub2-BIB0059|cit59","doi-asserted-by":"publisher","first-page":"e1000097","DOI":"10.1371\/journal.pmed.1000097","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"6","author":"Moher","year":"2009","journal-title":"PLoS Medicine"},{"issue":"2","key":"10.1002\/14651858.CD011780.pub2-BIB0060|cit60","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.vaccine.2011.11.018","article-title":"Intradermal fractional dose inactivated polio vaccine: a review of the literature","volume":"30","author":"Nelson","year":"2012","journal-title":"Vaccine"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD011780.pub2-BIB0061|cit61","doi-asserted-by":"publisher","first-page":"S161","DOI":"10.1093\/infdis\/jix038","article-title":"Intradermal administration of fractional doses of inactivated poliovirus vaccine: a dose-sparing option for polio immunization","volume":"216","author":"Okayasu","year":"2017","journal-title":"Journal of Infectious Diseases"},{"issue":"4","key":"10.1002\/14651858.CD011780.pub2-BIB0062|cit62","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1016\/j.immuni.2010.10.007","article-title":"Designing vaccines based on biology of human dendritic cell subsets","volume":"33","author":"Palucka","year":"2010","journal-title":"Immunity"},{"issue":"8","key":"10.1002\/14651858.CD011780.pub2-BIB0063|cit63","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1586\/14760584.2015.1052800","article-title":"Impact of inactivated poliovirus vaccine on mucosal immunity: implications for the polio eradication endgame","volume":"14","author":"Parker","year":"2015","journal-title":"Expert Review of Vaccines"},{"key":"10.1002\/14651858.CD011780.pub2-BIB0064|cit64","unstructured":"Nordic Cochrane Centre, The Cochrane Collaboration Review Manager 5 (RevMan 5) 2014"},{"key":"10.1002\/14651858.CD011780.pub2-BIB0065|cit65","unstructured":"Sch\u00fcnemann HJ Oxman AD Vist GE Higgins JPT Deeks JJ Glasziou P on behalf of the Cochrane Applicability and Recommendations Methods Group Chapter 12: Interpreting results and drawing conclusions. In: Higgins JPT, Green S, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from handbook.cochrane.org"},{"key":"10.1002\/14651858.CD011780.pub2-BIB0066|cit66","unstructured":"Sterne JAC Egger M Moher D editor(s) on behalf of the Cochrane Bias Methods Group Chapter 10: Addressing reporting biases. In: Higgins JPT, Green S, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from handbook.cochrane.org"},{"issue":"7","key":"10.1002\/14651858.CD011780.pub2-BIB0067|cit67","first-page":"52","article-title":"Case definitions for the four diseases requiring notification to WHO in all circumstances under the International Health Regulations (2005)","volume":"84","author":"World Health Organization","year":"2009","journal-title":"Weekly Epidemiological Record"},{"key":"10.1002\/14651858.CD011780.pub2-BIB0068|cit68","volume-title":"Polio Eradication & Endgame Strategic Plan 2013-2018","author":"World Health Organization","year":"2013"},{"issue":"12","key":"10.1002\/14651858.CD011780.pub2-BIB0069|cit69","first-page":"145","article-title":"Polio vaccines: WHO position paper - March, 2016","volume":"91","author":"World Health Organization","year":"2016","journal-title":"Weekly Epidemiological Record"},{"key":"10.1002\/14651858.CD011780.pub2-BIB0070|cit70","unstructured":"World Health Organization Poliomyelitis www.who.int\/mediacentre\/factsheets\/fs114\/en\/ (accessed June 2018)"},{"key":"10.1002\/14651858.CD011780.pub2-BIB0071|cit71","unstructured":"World Bank Data: World Bank country and lending groups bit.ly\/1pUHKTk"},{"issue":"6","key":"10.1002\/14651858.CD011780.pub2-BIB0072|cit72","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD011780","article-title":"Intradermal fractional dose vs intramuscular full dose of inactivated polio vaccine for prevention of poliomyelitis","author":"Jaiswal","year":"2015","journal-title":"Cochrane Database of Systematic Reviews"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cochranelibrary.com\/cdsr\/doi\/10.1002\/14651858.CD011780.pub2\/epdf\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,9]],"date-time":"2021-08-09T22:59:39Z","timestamp":1628549979000},"score":1,"resource":{"primary":{"URL":"https:\/\/doi.wiley.com\/10.1002\/14651858.CD011780.pub2"}},"subtitle":[],"editor":[{"name":"Cochrane Developmental, Psychosocial and Learning Problems Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2019,12,19]]},"references-count":72,"URL":"https:\/\/doi.org\/10.1002\/14651858.cd011780.pub2","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,12,19]]}}}